-
-
-
-
-
-
-
Seres Therapeutics names Richard Kender as interim CEO
-
-
-
-
-
-
-
Maze Therapeutics Appoints Industry Veteran Hervé Hoppenot as Chairman of the Board of Directors
-
-
-
-
-
-
-
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
-
-
-
-
-
-
-
B.Riley Downgrades Bicycle Therapeutics (BCYC) to Neutral
-
-
-
-
-
-
-
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Bicycle Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
1,199,636 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

